Movement Disorders

Filter Your Results

 

News

 

Emerging Gene Therapy for Parkinson’s Disease Creates New Brain Circuits

Friday, November 30, 2018—A recent study found that gene therapy in development for treatment of patients with Parkinson's disease creates new circuits in the brain associated with improved movemen…

Biases in Dementia Screening Tools

Wednesday, November 28, 2018—Brief cognitive tests are useful screening tools for dementia in the primary care setting; however, a study published in the journal Neurology Clinical Practice show…

Digital Health Coach Assists Patients with Parkinson’s Disease

Friday, November 16, 2018—Patients suffering from Parkinson’s disease (PD), as well as their caregivers and families, can utilize a new app called a “digital health coach” for continu…

Study Confirms Benefits of Laser Interstitial Thermal Therapy

Wednesday, November 14, 2018—A prospective, multi-center clinical study of 42 patients with brain lesions that recurred after stereotactic radiosurgery (SRS) for metastatic brain tumors showed p…

Effect of Pimavanserin for Parkinson’s Disease Psychosis Found Larger in Patients with Impaired Cognition

Friday, November 02, 2018—A post hoc analysis of data from the 6‐week phase 3 trial (NCT01174004) of pimavanserin (Nuplazid; Acadia Pharmaceuticals, San Diego, CA) in patients with Parkinson’s …

Positive Top-Line Results Announced from Phase 2 Study of Pimavanserin for Adjunctive Treatment of Major Depressive Disorder

Tuesday, October 30, 2018—Pimavanserin (Nuplazid; Acadia Pharmaceuticals, San Diego, CA), already approved for treatment of patients with Parkinson’s disease (PD) psychosis is also being studied …

Positive Two-Year Outcomes for Treatment of Essential Tremor With Focused Ultrasound

Tuesday, October 09, 2018—Patients with medically refractory essential tremor treated with magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy had a mean 43.4% reduction in their scores o…

Shortage of Sinemet Attribute to Manufacturing and Forecasting Issues

Thursday, October 04, 2018—The carbidopa-levodopa distributed under the brand names Sinemet and Sinemet Plus by Merck &Co. (Kenilworth, NJ) is out of stock and expected to be on back order through t…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC